HAROLD R WERNER
CIK 1013603 · last filed 2018-08-01
HAROLD R WERNER is a corporate insider who has filed 11 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for LPTX, was dated Aug 1, 2018. Across all open-market trades the lifetime net is +$1.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $25.6M across reported positions. 37 SEC filings were submitted jointly with JAMES H CAVANAUGH.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$25.60M
7
11
$1.81M
Filer Profile
44 NASSAU STREET
PRINCETON, NJ 08542
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted | 10%+ Owner | — | $1.56 | — | $0 | 1 | 2018-08-01 |
| GLOBEIMMUNE INC (GBIM) Delisted | 10%+ Owner | 564,267 | — | — | -$319.9K | 2 | 2016-02-19 |
| XNCR | Director | 1,035,407 | $24.72 | $25.60M | $0 | 1 | 2013-12-06 |
| Altimmune, Inc. (PIP) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2009-07-30 |
| MiddleBrook Pharmaceuticals, Inc. (MBRK) Delisted | Director | — | — | — | $0 | 2 | 2009-06-24 |
| GENVEC INC (GNVC) Delisted | Director | — | — | — | $0 | 1 | 2007-06-15 |
| MiddleBrook Pharmaceuticals, Inc. (AVNC) Delisted | Director | 11,863,327 | — | — | $2.13M | 2 | 2007-05-23 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-08-01 | CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted | Other (J) | — | $0 | EDGAR |
| 2016-02-19 | GLOBEIMMUNE INC (GBIM) Delisted | Sell (S) | −105,000 | -$151.2K | EDGAR |
| 2016-02-16 | GLOBEIMMUNE INC (GBIM) Delisted | Sell (S) | −105,000 | -$168.7K | EDGAR |
| 2013-12-06 | XNCR | Conv (C) | +1,035,407 | $0 | EDGAR |
| 2011-12-23 | — | Buy (P) | — | $0 | |
| 2009-07-30 | Altimmune, Inc. (PIP) Delisted | Mixed | — | $0 | EDGAR |
| 2009-06-24 | MiddleBrook Pharmaceuticals, Inc. (MBRK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-19 | MiddleBrook Pharmaceuticals, Inc. (MBRK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-15 | GENVEC INC (GNVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-23 | MiddleBrook Pharmaceuticals, Inc. (AVNC) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.